Notice of Proposed Sale · 144
Collegium Pharmaceutical, Inc.
COLLNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- COLLEGIUM PHARMACEUTICAL, INC
- Issuer CIK
- 0001267565
- SEC file number
- 001-37372
- Phone
- 781-713-3699
- Person for whose account securities are to be sold
- Dreyer Scott
- Relationships to issuer
- Former Officer
- Street
- 100 TECHNOLOGY CENTER DRIVE
- City
- STOUGHTON
- State / country code
- MA
- Postal code
- 02072
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 27,419 | 603,320.70 | 32,555,613 | 09/30/2026 | NASDAQ | Fidelity Brokerage Services LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Fidelity Brokerage Services LLC
- Street
- 900 Salem Street
- City
- Smithfield
- State / country code
- RI
- Postal code
- 02917
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 09/23/2026 | Restricted Stock Vesting | Issuer | 27,419 | N | 09/23/2026 | Compensation |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 09/30/2026
- Signed
- /s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Scott Dreyer.
Company context
Collegium Pharmaceutical is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. Collegium has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions.